REGORAFENIB vs RELATLIMAB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
REGORAFENIB vs RELATLIMAB: Safety Overview
| Metric | REGORAFENIB | RELATLIMAB |
|---|---|---|
| Total FAERS Reports | 9,441 | 177 |
| Deaths Reported | 1,869 | 29 |
| Death Rate | 19.8% | 16.4% |
| Hospitalizations | 3,363 | 145 |
| Average Patient Age | 62.2 yrs | 64.5 yrs |
| % Female Patients | 39.9% | 34.6% |
| FDA Approval Date | Jan 13, 2025 | N/A |
| Manufacturer | Bayer HealthCare Pharmaceuticals Inc. | N/A |
| Route | ORAL | N/A |
| Marketing Status | Prescription | N/A |